Trials / Completed
CompletedNCT04387955
Analysis of Chilblains pROfile During coVID-19 Epidemic (ACROVID)
Analysis of Chilblains Profile During COVID-19 Epidemic
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Poitiers University Hospital · Academic / Other
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Accepted
Summary
Cases of chilblains have been reported with an unusual frequency in France in the context of the COronaVirus Infectious Disease 2019 (COVID-19) epidemic. Some of these cases have been linked to a virological status in favour of a recent Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) infection. Chilblains are acral inflammatory lesion typically reactive to cold (primary form). There are secondary forms acquired during autoimmune connectivitis such as lupus chilblain or hereditary forms related to type I Interferonopathy. An interferon type I signature has been described in these secondary forms of frostbite but also during the cytokine storm of severe forms of CoV-2 SARS infection. If cases of frostbite are indeed secondary to an SARS-CoV-2 infection, comparative analysis of their immunopathological profiles could provide a better understanding of the inflammatory mechanisms during COVID-19.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Biological Sample Collection | * Diagnostic test : biological sample collection at Day 0 * Two skin biopsies on chilblain at Day 0 (one biopsy for histological analysis, one biopsy for basic research) * Anal swabbing at Day 0 * Blood test at Day 0 * Blood test at Month 1 * Blood test at Month 2 |
Timeline
- Start date
- 2020-04-30
- Primary completion
- 2021-07-30
- Completion
- 2021-07-30
- First posted
- 2020-05-14
- Last updated
- 2021-11-29
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04387955. Inclusion in this directory is not an endorsement.